Loading clinical trials...
Loading clinical trials...
A Phase 2 Randomized Trial of Remodeling Intestinal Microbiota Using Fecal Microbiome Transplant (FMT) Among Recipients of Chimeric Antigen Receptor T Cells (CAR T)
Conditions
Interventions
Axicabtagene Ciloleucel
Biospecimen Collection
+4 more
Locations
1
United States
City of Hope Medical Center
Duarte, California, United States
Start Date
February 11, 2026
Primary Completion Date
January 23, 2029
Completion Date
January 23, 2029
Last Updated
March 5, 2026
NCT05272384
NCT05755087
NCT07098364
NCT05672251
NCT06905509
NCT06859008
Lead Sponsor
City of Hope Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions